ISB News

Melding ISB and FHCRC Brain Power for Cancer Research

ISB's Ilya Shmulevich describes his lab's work in The Cancer Genome Atlas project and how ISB and FHCRC could collaborate.

(Photo above: ISB’s Dr. Ilya Shmulevich describes his lab’s work in The Cancer Genome Atlas project and how ISB and FHCRC could collaborate.)

Big health challenges require big science. Cancers are prime examples of overwhelmingly complex diseases that need the power of a cross-disciplinary, systems biology approach to decipher the underlying dysfunctional gene networks in order to find ways to prevent and manage the diseases and develop more effective therapies.

ISB's Dr. Nathan Price, left, chats with FHCRC's Dr. David Hockenbery and Dr. Eric Holland during a meeting held at Institute for Systems Biology to discuss potential collaborations on cancer research.

ISB’s Dr. Nathan Price, left, chats with FHCRC’s Dr. David Hockenbery and Dr. Eric Holland during a meeting held at Institute for Systems Biology to discuss potential collaborations on cancer research.

On May 6 at Institute for Systems Biology, researchers from ISB and Fred Hutchinson Cancer Research Center – specifically the Human Biology Division – gathered for a meeting of great minds to identify potential areas for collaboration. It was an intimate showcase for commingling ISB’s pioneering systems approach with the depth of cancer biology knowledge from FHCRC.

 

“We are laying the foundation for a strategic partnership that combines the best of both institutions to attack cancers with systems biology.”

Dr. Nitin Baliga, Senior Vice President and Director of ISB, and project coordinator Dr. Julie Bletz, worked with Dr. Eric Holland, Senior Vice President and Director of the Human Biology Division at FHCRC, to organize the day-long meeting. After introductions, 15 ISB and FHCRC researchers alternated to present their areas of expertise, research challenges, what strengths his/her group could bring to the table and what complementary collaboration the group seeks. The 15 rapid-fire presentations consisted of 15-minute research summaries plus 5 minutes for questions and answers.

The day concluded with group discussions on three topics: potential partnerships and funding opportunities that can be pursued at the investigator level; types of resources both institutions can share and invest in jointly; one or two big problems that both organizations can attack collectively.

“It was a great day, with lots of interesting discussions and potential for collaboration,” said Baliga. “We are laying the foundation for a strategic partnership that combines the best of both institutions to attack cancers with systems biology.”

Related Articles

  • Wei Wei Awarded CARE Grant

    The Andy Hill Cancer Research Endowment (CARE) is a public-private partnership that supports cancer research in Washington state. CARE announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.

    Read More
  • Town Hall Seattle panel

    Expert Panel Discusses 21st Century Health at Town Hall Seattle Event

    In a public panel discussion put on by Town Hall Seattle and ISB, legendary biologist Dr. Lee Hood, PSJH Chief Clinical Officer Dr. Amy Compton-Phillips, and PATH’s Program Leader of Diagnostics Tala de los Santos addressed the promise — and challenges — of implementing and practicing 21st century health care.

    Read More
  • Qiang Tian, MD, PhD

    ISB’s Dr. Qiang Tian Joins Shanghai’s National Research Center for Translational Medicine

    In the two decades since joining Dr. Lee Hood as a postdoc, Dr. Qiang Tian has made a tremendous impact on ISB’s science and culture. March 31 is his final day at ISB, as he is returning to China and joining Shanghai’s National Research Center for Translational Medicine.

    Read More
Show More Articles